Pulmonary hypertension in infants with congenital heart defects: are leukotrienes involved?
The circulating levels of leukotriene E4 in infants with congenital heart defects, increased pulmonary blood flow and pulmonary arterial hypertension, were determined and compared with infants with decreased pulmonary blood flow (Tetralogy of Fallot). There was no correlation (r=0.38) between the pu...
Saved in:
Main Authors: | A. Serraf, J-P. Gascard, J. Bruniaux, C. Labat, C. Planche, C. Brink |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1997-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629359791451 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On the involvement of the second heart field in congenital heart defects
by: Guijarro, Clara, et al.
Published: (2024-03-01) -
Heterotaxy syndrome, dextrocardia, ureteropelvic obstruction, endometriosis, and pulmonary hypertension in an adult with congenital heart defects: a case report
by: Ahmad Al-Bitar, et al.
Published: (2025-01-01) -
Postoperative Pulmonary Hemodynamics and Systemic Inflammatory Response in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
by: Maria Francilene S. Souza, et al.
Published: (2022-01-01) -
Prevalence of congenital defects of heart and large vessels in adults
by: I.G. Lebid
Published: (2017-03-01) -
An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
by: Reda Ibrahim, et al.
Published: (2006-01-01)